SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001764013-20-000062
Filing Date
2020-11-12
Accepted
2020-11-12 08:28:22
Documents
2
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K imvt-20200930x8xk.htm 8-K 23124
2 EX-99.1 exhibit991q2.htm EX-99.1 74801
  Complete submission text file 0001764013-20-000062.txt   99085
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38906 | Film No.: 201303577
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences